Table 4.
Preoperative clinical risk factors for 5-year PFS in patients with EC.
Variable | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age (years) | 1.037 (1.012, 1.062) |
0.004 | 1.035 (1.007, 1.064) |
0.013 |
BMI | 1.085 (1.032, 1.140) |
0.001 | 1.084 (1.025, 1.146) |
0.005 |
CA125 | 1.000 (1.000, 1.000) |
0.114 | ||
HE4 | 1.010 (1.003, 1.018) |
0.006 | 1.011 (1.003, 1.020) |
0.010 |
Hypertension | 0.604 | |||
No | 1.000 | |||
Yes | 0.832 (0.416, 1.664) |
|||
Diabetes | 0.193 | |||
No | 1.000 | |||
Yes | 1.555 (0.800, 3.025) |
|||
Maximum Diameter | 1.934 (1.367, 2.737) |
<0.001 | 2.000 (1.362, 2.936) |
<0.001 |
DMI | 0.641 | |||
No | 1.000 | |||
Yes | 0.858 (0.450, 1.636) |
|||
PLN | 0.229 | |||
No | 1.000 | |||
Yes | 1.488 (0.779, 2.843) |
|||
PALN | 0.004 | 0.023 | ||
No | 1.000 | 1.000 | ||
Yes | 2.836 (1.383, 5.814) |
2.590 (1.140, 5.885) |
BMI, body mass index; presence of hypertension and diabetes; CA125, carbohydrate antigen 125; HE4, human epididymis protein 4; HBP, high blood pressure; DMI, deep myometrial invasion; PLN, pelvic lymph nodes; PALN, para-aortic lymph nodes. Bold type indicates statistically significant difference.